The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind, placebo-controlled phase Ib/II study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine (G) and carboplatin (C) versus GC for women with recurrent platinum-sensitive ovarian cancer.
 
Ignace Vergote
Consulting or Advisory Role - Advaxis (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (Inst); Genmab (Inst); Immunogen (Inst); Millennium (Inst); MSD Belgium (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst); Stichting tegen kanker (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genmab; PharmaMar; Roche; Takeda; Tesaro
 
Florian Heitz
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Tesaro
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - PharmaMar; Tesaro
 
Paul Buderath
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro
 
Jalid Sehouli
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Merck; MSD Oncology; Pfizer; PharmaMar; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Christine M. Lee
No Relationships to Disclose
 
Anne L. Hamilton
Research Funding - Abbvie (Inst); Amgen (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst)
 
James Fiorica
No Relationships to Disclose
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - AstraZeneca
 
Michael Teneriello
No Relationships to Disclose
 
Lisa Golden
No Relationships to Disclose
 
Wei Zhang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Celine Pitou
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Daphne L. Farrington
Employment - Lilly; Verastem
Stock and Other Ownership Interests - Lilly; Lilly (I); Sesen Bio; Sesen Bio (I); Verastem; Verastem (I)
 
Katherine M Bell-McGuinn
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Tesaro
Consulting or Advisory Role - Clovis Oncology; Genentech; Merck; Mersana; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech; Tesaro
Research Funding - Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - TapImmune Inc.